Crossmark

S1P receptor 1 antagonist ponesimod alleviates postherpetic neuralgia in rats by normalizing spinal TRPV1 expression and inhibiting MAPK-mediated glial activation

Crossref DOI link: https://doi.org/10.1007/s10616-025-00806-7

Published Online: 2025-07-08

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Meixin

Wang, Yuanhong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81873312, 81873312)

Natural Science Foundation of Heilongjiang Province (LH2022H077,H201462, LH2022H077,H201462)

Harbin Science and Technology Innovation Talent Research Project (2016RAXYJ102, 2016RAXYJ102)
License Information

Text and Data Mining valid from 2025-07-08

Version of Record valid from 2025-07-08
More Information

Article History

Received: 12 May 2025

Accepted: 25 June 2025

First Online: 8 July 2025

Declarations

:

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below